Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study
暂无分享,去创建一个
N. Sakamoto | M. Natsuizaka | J. Yoshida | T. Meguro | A. Nagasaka | Yoshiya Yamamoto | T. Sho | Tomoe Kobayashi | K. Morikawa | Koji Ogawa | N. Kawagishi | G. Suda | M. Kimura | K. Terashita | M. Ohara | M. Nakai | Yoko Tsukuda | Ken Furuya | I. Tsunematsu | J. Ito | M. Umemura | T. Izumi | Munenori Okamoto | Kenichi Morikawa